TheCable

President Muhammadu Buhari has approved the reappointment of Mojisola Adeyeye as the director-general of the National Agency for Food and Drug Administration and Control (NAFDAC).

Her tenure expired on November 12 and she stopped reporting to office.

The reappointment was disclosed in a statement by Abubakar Jimoh, director of public affairs of the agency, on Friday.

“President Muhammadu Buhari (GCFR) has reappointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Christianah Adeyeye, for a second tenure of five years,” the statement reads.

“The Secretary to the Government of the Federation, Mr. Boss Mustapha (CFR), conveyed the approval of the President to Prof. Adeyeye whose tenure renewal took effect from 1st December, 2022.

“The Director-General’s reappointment came closely on the heels of her track record of monumental achievements and successes in the last five years, especially the attainment of World Health Organisation (WHO) Maturity Level 3.

“Prof. Adeyeye who officially assumed duty today (Friday) was received by some staff at the Corporate Headquarters in Abuja. She will be unfolding her plans for the second tenure after the holidays.”

The development comes weeks after speculations over whether she would be reappointed, considering that Adeyeye’s first five-year tenure ended in November 2022.

On November 25, NAFDAC, in an unusual public notice, announced the expiration of Adeyeye’s tenure, saying Monica Eimunjeze had been appointed the acting director-general.

“The Management of NAFDAC wishes to inform all stakeholders and the general public about the expiration of the tenure of office of her Director-General, Prof. Mojisola Christianah Adeyeye,” NAFDAC had said.

“Consequently, the Federal Government has appointed the Agency’s Director of Drug Registration and Regulatory Affairs, Dr. Monica Hemben Eimunjeze as Acting Director-General with effect from 12th November, 2022.”